Search results

Selected filters:

Technology Licensing
Africa & Middle East

Article type

Topic

Sector

Jurisdictions

9 results found for your search

Sort options
17 June 2019

Why it's time for the world of patents to embrace diversity and gender equality

Special IAM boardroom session at IPBC Global 2019 focuses on how to get more women involved in senior positions in the global IP market - and why everyone will win when it happens

05 April 2019

Another Chinese mobile giant approaches IPO light on patents and facing potential trouble as a result

Shenzhen-based Transsion is a dominant market player in Africa, but a light IP portfolio might complicate its ambitious expansion plans

07 March 2019

More technology transfer needed for effective climate change mitigation  

Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms    

06 March 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy 

31 January 2019

Latest Samsung acquisition could re-ignite patent war with Apple

The Korean electronics giant has bought Corephotonics, an Israeli startup that is taking on Apple in Judge Lucy Koh’s Northern District of California courtroom

23 January 2019

Welcome to the future of patents

New IAM research reports identify the key trends shaping the global IP market – and tell you how to respond

26 April 2018

Israeli startup litigating with Apple inks camera tech licence with Oppo

Corephotonics, a developer of dual camera technologies based in Tel Aviv, last week announced a licensing agreement with Chinese smartphone maker Oppo. It appears to be the first publicly announced IP licence with a major smartphone OEM for the…

28 September 2015

Novartis is the latest Big Pharma player to extend olive branch in Third World patent rights row

While the global quarrel over the pricing of patented drugs continues unabated, Swiss pharmaceutical giant Novartis has announced that it will offer a number of its medicines at significant discount to developing countries. According to a press…

17 June 2015

A new approach to the reform debate; China's IP future; the European tide; and much more at IPBC Global Day 3

IPBC Global in San Francisco is now finished, but only after another compelling day of sessions, networking and discussion. Here, IAM’s editorial team – Joff Wild, Richard Lloyd, Jack Ellis and Sara Jayne Clover – pick out a few of the highlights: …